(Q38653464)

5 September 2017

title

How many carbonic anhydrase inhibition mechanisms exist? (English)

1 reference

5 September 2017

1

Claudiu T Supuran

1 reference

5 September 2017

publication date

30 November 2015

1 reference

Journal of Enzyme Inhibition and Medicinal Chemistry

5 September 2017

published in

1 reference

5 September 2017

volume

31

1 reference

5 September 2017

issue

3

1 reference

5 September 2017

page(s)

345-360

1 reference

Carbonic anhydrases: novel therapeutic applications for inhibitors and activators

5 September 2017

cites work

1 reference

https://api.crossref.org/works/10.3109%2F14756366.2015.1122001

Interfering with pH regulation in tumours as a therapeutic strategy

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F14756366.2015.1122001

An overview of the alpha-, beta- and gamma-carbonic anhydrases from Bacteria: can bacterial carbonic anhydrases shed new light on evolution of bacteria?

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F14756366.2015.1122001

The η-class carbonic anhydrases as drug targets for antimalarial agents

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F14756366.2015.1122001

Structure-based drug discovery of carbonic anhydrase inhibitors

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F14756366.2015.1122001

Carbonic anhydrase inhibitors

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F14756366.2015.1122001

Carbonic anhydrases: current state of the art, therapeutic applications and future prospects

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F14756366.2015.1122001

Carbonic anhydrase inhibitors and activators for novel therapeutic applications

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F14756366.2015.1122001

Bacterial carbonic anhydrases as drug targets: toward novel antibiotics?

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F14756366.2015.1122001

Carbonic anhydrase inhibitors

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F14756366.2015.1122001

(In)organic anions as carbonic anhydrase inhibitors

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F14756366.2015.1122001

Biochemical characterization of recombinant β-carbonic anhydrase (PgiCAb) identified in the genome of the oral pathogenic bacterium Porphyromonas gingivalis.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F14756366.2015.1122001

Carbonic anhydrase inhibitors: an editorial.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F14756366.2015.1122001

Anti-infective carbonic anhydrase inhibitors: a patent and literature review

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F14756366.2015.1122001

Sulfa and trimethoprim-like drugs - antimetabolites acting as carbonic anhydrase, dihydropteroate synthase and dihydrofolate reductase inhibitors

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F14756366.2015.1122001

Carbonic anhydrases as targets for medicinal chemistry

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F14756366.2015.1122001

Targeting tumor hypoxia: suppression of breast tumor growth and metastasis by novel carbonic anhydrase IX inhibitors.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F14756366.2015.1122001

Carbonic anhydrase inhibitors. Inhibition of the prokariotic beta and gamma-class enzymes from Archaea with sulfonamides

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F14756366.2015.1122001

Multiple binding modes of inhibitors to carbonic anhydrases: how to design specific drugs targeting 15 different isoforms?

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F14756366.2015.1122001

Carbonic anhydrase inhibitors. X-ray crystal studies of the carbonic anhydrase II-trithiocarbonate adduct--an inhibitor mimicking the sulfonamide and urea binding to the enzyme

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F14756366.2015.1122001

Carbonic anhydrase activators: X-ray crystallographic and spectroscopic investigations for the interaction of isozymes I and II with histamine

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F14756366.2015.1122001

Carbonic anhydrase activators. Activation of isozymes I, II, IV, VA, VII, and XIV with l- and d-histidine and crystallographic analysis of their adducts with isoform II: engineering proton-transfer processes within the active site of an enzyme.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F14756366.2015.1122001

Sulfonamide inhibition studies of the γ-carbonic anhydrase from the Antarctic cyanobacterium Nostoc commune.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F14756366.2015.1122001

Structure and inhibition of the CO2-sensing carbonic anhydrase Can2 from the pathogenic fungus Cryptococcus neoformans

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F14756366.2015.1122001

Dithiocarbamates Strongly Inhibit Carbonic Anhydrases and Show Antiglaucoma Action in Vivo

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F14756366.2015.1122001

Dithiocarbamates strongly inhibit the β-class carbonic anhydrases from Mycobacterium tuberculosis

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F14756366.2015.1122001

The alpha and beta classes carbonic anhydrases from Helicobacter pylori as novel drug targets

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F14756366.2015.1122001

Molecular cloning, characterization, and inhibition studies of the Rv1284 beta-carbonic anhydrase from Mycobacterium tuberculosis with sulfonamides and a sulfamate

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F14756366.2015.1122001

Carbonic anhydrase inhibitors. Cloning, characterization, and inhibition studies of a new beta-carbonic anhydrase from Mycobacterium tuberculosis

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F14756366.2015.1122001

Discovery of low nanomolar and subnanomolar inhibitors of the mycobacterial beta-carbonic anhydrases Rv1284 and Rv3273

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F14756366.2015.1122001

Carbonic anhydrase inhibitors. Characterization and inhibition studies of the most active beta-carbonic anhydrase from Mycobacterium tuberculosis, Rv3588c.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F14756366.2015.1122001

The β-carbonic anhydrases from Mycobacterium tuberculosis as drug targets.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F14756366.2015.1122001

Brucella carbonic anhydrases: new targets for designing anti-infective agents

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F14756366.2015.1122001

Inhibition studies with anions and small molecules of two novel β-carbonic anhydrases from the bacterial pathogen Salmonella enterica serovar Typhimurium

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F14756366.2015.1122001

Inhibition of the β-class carbonic anhydrases from Mycobacterium tuberculosis with carboxylic acids

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F14756366.2015.1122001

Inhibition studies of a beta-carbonic anhydrase from Brucella suis with a series of water soluble glycosyl sulfanilamides.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F14756366.2015.1122001

Unexpected nanomolar inhibition of carbonic anhydrase by COX-2-selective celecoxib: new pharmacological opportunities due to related binding site recognition

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F14756366.2015.1122001

Carbonic anhydrase inhibitors: Valdecoxib binds to a different active site region of the human isoform II as compared to the structurally related cyclooxygenase II "selective" inhibitor celecoxib

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F14756366.2015.1122001

Saccharin inhibits carbonic anhydrases: possible explanation for its unpleasant metallic aftertaste

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F14756366.2015.1122001

Carbonic anhydrase inhibitors. A general approach for the preparation of water-soluble sulfonamides incorporating polyamino-polycarboxylate tails and of their metal complexes possessing long-lasting, topical intraocular pressure-lowering properties.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F14756366.2015.1122001

Taking advantage of tumor cell adaptations to hypoxia for developing new tumor markers and treatment strategies

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F14756366.2015.1122001

Hypoxia activates the capacity of tumor-associated carbonic anhydrase IX to acidify extracellular pH.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F14756366.2015.1122001

Imaging of CA IX with fluorescent labelled sulfonamides distinguishes hypoxic and (re)-oxygenated cells in a xenograft tumour model

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F14756366.2015.1122001

In vivo targeting of tumor-associated carbonic anhydrases using acetazolamide derivatives

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F14756366.2015.1122001

Ureido-substituted benzenesulfonamides potently inhibit carbonic anhydrase IX and show antimetastatic activity in a model of breast cancer metastasis.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F14756366.2015.1122001

The development of topically acting carbonic anhydrase inhibitors as anti-glaucoma agents

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F14756366.2015.1122001

Novel therapies for glaucoma: a patent review 2007 - 2011.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F14756366.2015.1122001

Nitric oxide-donating carbonic anhydrase inhibitors for the treatment of open-angle glaucoma

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F14756366.2015.1122001

Synthesis and crystallographic analysis of new sulfonamides incorporating NO-donating moieties with potent antiglaucoma action

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F14756366.2015.1122001

Carbonic anhydrase inhibitors: inhibition of human, bacterial, and archaeal isozymes with benzene-1,3-disulfonamides--solution and crystallographic studies

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F14756366.2015.1122001

Coumarinyl-substituted sulfonamides strongly inhibit several human carbonic anhydrase isoforms: solution and crystallographic investigations

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F14756366.2015.1122001

Conformational variability of different sulfonamide inhibitors with thienyl-acetamido moieties attributes to differential binding in the active site of cytosolic human carbonic anhydrase isoforms

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F14756366.2015.1122001

Selective hydrophobic pocket binding observed within the carbonic anhydrase II active site accommodate different 4-substituted-ureido-benzenesulfonamides and correlate to inhibitor potency

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F14756366.2015.1122001

Sulfonamides incorporating 1,3,5-triazine moieties selectively and potently inhibit carbonic anhydrase transmembrane isoforms IX, XII and XIV over cytosolic isoforms I and II: Solution and X-ray crystallographic studies

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F14756366.2015.1122001

Anticonvulsant 4-aminobenzenesulfonamide derivatives with branched-alkylamide moieties: X-ray crystallography and inhibition studies of human carbonic anhydrase isoforms I, II, VII, and XIV

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F14756366.2015.1122001

Characterization and inhibition studies of an α-carbonic anhydrase from the endangered sturgeon species Acipenser gueldenstaedti.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F14756366.2015.1122001

Carbonic anhydrase inhibitors. Phenacetyl-, pyridylacetyl- and thienylacetyl-substituted aromatic sulfonamides act as potent and selective isoform VII inhibitors

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F14756366.2015.1122001

Carbonic anhydrase inhibitors. Aromatic/heterocyclic sulfonamides incorporating phenacetyl, pyridylacetyl and thienylacetyl tails act as potent inhibitors of human mitochondrial isoforms VA and VB.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F14756366.2015.1122001

Carbonic anhydrase inhibitors: synthesis and inhibition of cytosolic/tumor-associated carbonic anhydrase isozymes I, II, and IX with sulfonamides incorporating 1,2,4-triazine moieties

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F14756366.2015.1122001

Carbonic anhydrase inhibitors: novel sulfonamides incorporating 1,3,5-triazine moieties as inhibitors of the cytosolic and tumour-associated carbonic anhydrase isozymes I, II and IX.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F14756366.2015.1122001

Recent developments in targeting carbonic anhydrase IX for cancer therapeutics

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F14756366.2015.1122001

Sulfonamides: a patent review (2008 - 2012).

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F14756366.2015.1122001

Antiglaucoma carbonic anhydrase inhibitors: a patent review

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F14756366.2015.1122001

Anticancer carbonic anhydrase inhibitors: a patent review (2008 - 2013).

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F14756366.2015.1122001

Diuretics with carbonic anhydrase inhibitory action: a patent and literature review (2005 - 2013).

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F14756366.2015.1122001

Antiobesity carbonic anhydrase inhibitors: a literature and patent review

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F14756366.2015.1122001

Acetazolamide for the treatment of idiopathic intracranial hypertension

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F14756366.2015.1122001

Exploiting the hydrophobic and hydrophilic binding sites for designing carbonic anhydrase inhibitors

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F14756366.2015.1122001

Dithiocarbamates: a new class of carbonic anhydrase inhibitors. Crystallographic and kinetic investigations

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F14756366.2015.1122001

Xanthates and trithiocarbonates strongly inhibit carbonic anhydrases and show antiglaucoma effects in vivo.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F14756366.2015.1122001

Hit Recycling: Discovery of a Potent Carbonic Anhydrase Inhibitor by in Silico Target Fishing.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F14756366.2015.1122001

Carbonic anhydrase inhibitors. Interaction of isozymes I, II, IV, V, and IX with carboxylates

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F14756366.2015.1122001

Carbonic anhydrase inhibitors. Interaction of isozymes I, II, IV, V, and IX with phosphates, carbamoyl phosphate, and the phosphonate antiviral drug foscarnet

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F14756366.2015.1122001

Phosph(on)ate as a zinc-binding group in metalloenzyme inhibitors: X-ray crystal structure of the antiviral drug foscarnet complexed to human carbonic anhydrase I

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F14756366.2015.1122001

Dual carbonic anhydrase/matrix metalloproteinase inhibitors incorporating bisphosphonic acid moieties targeting bone tumors

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F14756366.2015.1122001

Carbamoylphosphonates control tumor cell proliferation and dissemination by simultaneously inhibiting carbonic anhydrase IX and matrix metalloproteinase-2. Toward nontoxic chemotherapy targeting tumor microenvironment

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F14756366.2015.1122001

Protease inhibitors: synthesis of bacterial collagenase and matrix metalloproteinase inhibitors incorporating succinyl hydroxamate and iminodiacetic acid hydroxamate moieties

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F14756366.2015.1122001

Hydroxyurea is a carbonic anhydrase inhibitor

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F14756366.2015.1122001

Dual inhibitors of matrix metalloproteinases and carbonic anhydrases: iminodiacetyl-based hydroxamate-benzenesulfonamide conjugates.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F14756366.2015.1122001

Hydroxamate represents a versatile zinc binding group for the development of new carbonic anhydrase inhibitors

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F14756366.2015.1122001

A Combined Crystallographic and Theoretical Study Explains the Capability of Carboxylic Acids to Adopt Multiple Binding Modes in the Active Site of Carbonic Anhydrases

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F14756366.2015.1122001

Polyamines inhibit carbonic anhydrases by anchoring to the zinc-coordinated water molecule

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F14756366.2015.1122001

Carbonic anhydrase inhibitors: interactions of phenols with the 12 catalytically active mammalian isoforms (CA I-XIV).

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F14756366.2015.1122001

Carbonic anhydrase inhibitors: inhibition of mammalian isoforms I-XIV with a series of substituted phenols including paracetamol and salicylic acid

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F14756366.2015.1122001

In vitro inhibition of salicylic acid derivatives on human cytosolic carbonic anhydrase isozymes I and II.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F14756366.2015.1122001

Carbonic anhydrase inhibitors. Inhibition of human erythrocyte isozymes I and II with a series of antioxidant phenols.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F14756366.2015.1122001

Carbonic anhydrase inhibitors. Inhibition of mammalian isoforms I-XIV with a series of natural product polyphenols and phenolic acids

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F14756366.2015.1122001

Carbonic anhydrase inhibitors. Identification of selective inhibitors of the human mitochondrial isozymes VA and VB over the cytosolic isozymes I and II from a natural product-based phenolic library

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F14756366.2015.1122001

Natural product-based phenols as novel probes for mycobacterial and fungal carbonic anhydrases

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F14756366.2015.1122001

Nucleophile recognition as an alternative inhibition mode for benzoic acid based carbonic anhydrase inhibitors

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F14756366.2015.1122001

Sulfocoumarins (1,2-benzoxathiine-2,2-dioxides): a class of potent and isoform-selective inhibitors of tumor-associated carbonic anhydrases

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F14756366.2015.1122001

Inhibition of the β-carbonic anhydrases from Mycobacterium tuberculosis with C-cinnamoyl glycosides: identification of the first inhibitor with anti-mycobacterial activity

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F14756366.2015.1122001

Synthesis of C-cinnamoyl glycosides and their inhibitory activity against mammalian carbonic anhydrases

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F14756366.2015.1122001

Carbonic anhydrase inhibitors: in vitro inhibition of α isoforms (hCA I, hCA II, bCA III, hCA IV) by flavonoids.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F14756366.2015.1122001

Inhibition of carbonic anhydrase isozymes I and II with natural products extracted from plants, mushrooms and honey.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F14756366.2015.1122001

Carbonic anhydrase inhibition with natural products: novel chemotypes and inhibition mechanisms

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F14756366.2015.1122001

New natural product carbonic anhydrase inhibitors incorporating phenol moieties

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F14756366.2015.1122001

Structural Studies of β-Carbonic Anhydrase from the Green Alga Coccomyxa: Inhibitor Complexes with Anions and Acetazolamide

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F14756366.2015.1122001

Non-zinc mediated inhibition of carbonic anhydrases: coumarins are a new class of suicide inhibitors

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F14756366.2015.1122001

Deciphering the mechanism of carbonic anhydrase inhibition with coumarins and thiocoumarins

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F14756366.2015.1122001

The coumarin-binding site in carbonic anhydrase accommodates structurally diverse inhibitors: the antiepileptic lacosamide as an example and lead molecule for novel classes of carbonic anhydrase inhibitors

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F14756366.2015.1122001

Glycosyl coumarin carbonic anhydrase IX and XII inhibitors strongly attenuate the growth of primary breast tumors.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F14756366.2015.1122001

Novel coumarins and benzocoumarins acting as isoform-selective inhibitors against the tumor-associated carbonic anhydrase IX.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F14756366.2015.1122001

Coumarins incorporating hydroxy- and chloro-moieties selectively inhibit the transmembrane, tumor-associated carbonic anhydrase isoforms IX and XII over the cytosolic ones I and II.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F14756366.2015.1122001

7,8-disubstituted- but not 6,7-disubstituted coumarins selectively inhibit the transmembrane, tumor-associated carbonic anhydrase isoforms IX and XII over the cytosolic ones I and II in the low nanomolar/subnanomolar range

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F14756366.2015.1122001

7-Amino-3,4-dihydro-1H-quinolin-2-one, a compound similar to the substituted coumarins, inhibits α-carbonic anhydrases without hydrolysis of the lactam ring.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F14756366.2015.1122001

7-Substituted-sulfocoumarins are isoform-selective, potent carbonic anhydrase II inhibitors.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F14756366.2015.1122001

6-Substituted sulfocoumarins are selective carbonic anhdydrase IX and XII inhibitors with significant cytotoxicity against colorectal cancer cells

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F14756366.2015.1122001

Out of the active site binding pocket for carbonic anhydrase inhibitors

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F14756366.2015.1122001

Secondary and tertiary sulfonamides: a patent review (2008 - 2012).

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F14756366.2015.1122001

Synthesis of 3,4-dihydroxypyrrolidine-2,5-dione and 3,5-dihydroxybenzoic acid derivatives and evaluation of the carbonic anhydrase I and II inhibition.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F14756366.2015.1122001

Superacid synthesis of halogen containing N-substituted-4-aminobenzene sulfonamides: new selective tumor-associated carbonic anhydrase inhibitors

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F14756366.2015.1122001

New superacid synthesized (fluorinated) tertiary benzenesulfonamides acting as selective hCA IX inhibitors: toward a new mode of carbonic anhydrase inhibition by sulfonamides

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F14756366.2015.1122001

Selective inhibition of human carbonic anhydrases by novel amide derivatives of probenecid: synthesis, biological evaluation and molecular modelling studies.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F14756366.2015.1122001

The protein tyrosine kinase inhibitors imatinib and nilotinib strongly inhibit several mammalian alpha-carbonic anhydrase isoforms.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F14756366.2015.1122001

Spacer-based selectivity in the binding of "two-prong" ligands to recombinant human carbonic anhydrase I.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F14756366.2015.1122001

Ultrahigh resolution crystal structures of human carbonic anhydrases I and II complexed with "two-prong" inhibitors reveal the molecular basis of high affinity

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F14756366.2015.1122001

Carbonic anhydrase inhibitors: two-prong versus mono-prong inhibitors of isoforms I, II, IX, and XII exemplified by photochromic cis-1,2-alpha-dithienylethene derivatives

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F14756366.2015.1122001

Sulfonamides containing coumarin moieties selectively and potently inhibit carbonic anhydrases II and IX: design, synthesis, inhibitory activity and 3D-QSAR analysis.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F14756366.2015.1122001

Optimization of heterocyclic substituted benzenesulfonamides as novel carbonic anhydrase IX inhibitors and their structure activity relationship.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F14756366.2015.1122001

A highly selective space-folded photo-induced electron transfer fluorescent probe for carbonic anhydrase isozymes IX and its applications for biological imaging

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F14756366.2015.1122001

Targeting tumour hypoxia to prevent cancer metastasis. From biology, biosensing and technology to drug development: the METOXIA consortium

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F14756366.2015.1122001

Recent advances in the discovery of zinc-binding motifs for the development of carbonic anhydrase inhibitors.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F14756366.2015.1122001

Anticonvulsant O-alkyl sulfamates. 2,3:4,5-Bis-O-(1-methylethylidene)-beta-D-fructopyranose sulfamate and related compounds

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F14756366.2015.1122001

Carbonic anhydrase inhibitors: SAR and X-ray crystallographic study for the interaction of sugar sulfamates/sulfamides with isozymes I, II and IV.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F14756366.2015.1122001

A class of sulfonamide carbonic anhydrase inhibitors with neuropathic pain modulating effects

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F14756366.2015.1122001

Acetazolamide protects steatotic liver grafts against cold ischemia reperfusion injury.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F14756366.2015.1122001

Carbonic anhydrase inhibition for the management of cerebral ischemia: in vivo evaluation of sulfonamide and coumarin inhibitors.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F14756366.2015.1122001

A Key Opinion Leader interview: insight into the research and career of Prof. Claudiu T Supuran.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F14756366.2015.1122001

Carbonic anhydrase inhibitors. Part 37. Novel classes of isozyme I and II inhibitors and their mechanism of action. Kinetic and spectroscopic investigations on native and cobalt-substituted enzymes

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F14756366.2015.1122001

Carbonic anhydrase and matrix metalloproteinase inhibitors. Inhibition of human tumor-associated isozymes IX and cytosolic isozyme I and II with sulfonylated hydroxamates

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F14756366.2015.1122001

Protein–Protein Interactions: Inhibition of Mammalian Carbonic Anhydrases I–XV by the Murine Inhibitor of Carbonic Anhydrase and Other Members of the Transferrin Family

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F14756366.2015.1122001

Dithiocarbamates are strong inhibitors of the beta-class fungal carbonic anhydrases from Cryptococcus neoformans, Candida albicans and Candida glabrata

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F14756366.2015.1122001

Carbonic anhydrase inhibitors. Inhibition of the β-class enzymes from the fungal pathogens Candida albicans and Cryptococcus neoformans with branched aliphatic/aromatic carboxylates and their derivatives

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F14756366.2015.1122001

Inhibition of the alpha- and beta-carbonic anhydrases from the gastric pathogenHelycobacter pyloriwith anions

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F14756366.2015.1122001

Carbonic anhydrase inhibitors: The β-carbonic anhydrase from Helicobacter pylori is a new target for sulfonamide and sulfamate inhibitors

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F14756366.2015.1122001

Carbonic Anhydrase Inhibitors: Water-Soluble 4-Sulfamoylphenylthioureas as Topical Intraocular Pressure-Lowering Agents with Long-Lasting Effects

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F14756366.2015.1122001

Carbonic Anhydrase Inhibitors: X-ray and Molecular Modeling Study for the Interaction of a Fluorescent Antitumor Sulfonamide with Isozyme II and IX

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F14756366.2015.1122001

Carbonic Anhydrase Inhibitors. Synthesis of Water-Soluble, Topically Effective, Intraocular Pressure-Lowering Aromatic/Heterocyclic Sulfonamides Containing Cationic or Anionic Moieties: Is the Tail More Important than the Ring?1

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F14756366.2015.1122001

Carbonic anhydrase inhibitors

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F14756366.2015.1122001

Carbonic Anhydrase and Matrix Metalloproteinase Inhibitors: Sulfonylated Amino Acid Hydroxamates with MMP Inhibitory Properties Act as Efficient Inhibitors of CA Isozymes I, II, and IV, andN-Hydroxysulfonamides Inhibit Both These Zinc Enzymes1

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F14756366.2015.1122001

Carbonic anhydrase inhibitors: Inhibition of cytosolic/tumor-associated isoforms I, II, and IX with iminodiacetic carboxylates/hydroxamates also incorporating benzenesulfonamide moieties

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F14756366.2015.1122001

Synthesis of a new series of dithiocarbamates with effective human carbonic anhydrase inhibitory activity and antiglaucoma action

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F14756366.2015.1122001

Mono-/dihydroxybenzoic acid esters and phenol pyridinium derivatives as inhibitors of the mammalian carbonic anhydrase isoforms I, II, VII, IX, XII and XIV

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F14756366.2015.1122001

5- and 6-Membered (thio)lactones are prodrug type carbonic anhydrase inhibitors

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F14756366.2015.1122001

6-Substituted 1,2-benzoxathiine-2,2-dioxides are isoform-selective inhibitors of human carbonic anhydrases IX, XII and VA

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F14756366.2015.1122001

10.3109/14756366.2015.1122001

21 January 2018

Identifiers

DOI

1 reference

5 September 2017

1 reference